Califf asks Woodcock to stay in FDA leadership role if he’s confirmed
Rumors have swirled in Washington that Woodcock, a 35-year veteran of the FDA, would retire from the federal government.
Rumors have swirled in Washington that Woodcock, a 35-year veteran of the FDA, would retire from the federal government.
Antiviral pills for Covid-19 will need to be delivered quickly. Virtual care companies think they can speed up the process.
The case is in an adult male Minnesota resident who had been vaccinated and who recently had been in New York City attending a convention.
Sequencing itself can be as fast as a 24- to 48-hour turnaround. It’s the logistics of moving samples around that’s the real bottleneck.
The White House said the plan will push for more boosters, free at-home testing, and emergency response teams to be deployed this winter.
Scientists have learned to efficiently manufacture realistic models of 4- to 7-day-old human embryos from stem cells.
In the latest edition of STAT Health Tech: skepticism about AI in radiology, what patients think of hybrid care, and Elizabeth Holmes on defense.
Liquid biopsies could one day help detect countless cancers. But it’s still up for debate how widely they should be used.
Pain is increasingly being recognized as a key feature of long Covid. The medical establishment has been sluggish in acknowledging it.
Amgen is the latest big drug maker to curtail discounts offered through a federal program for safety-net hospitals and clinics.